BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1752784)

  • 1. Prognostic significance of circulating immune complexes in cancer patients.
    Dass TK; Aziz M; Rattan A
    Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
    Aziz M; Akhtar S; Malik A
    Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility and monitoring of breast cancer by circulating immune complexes.
    Dass TK; Aziz M; Rattan A; Tyagi SP
    Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
    Aziz M; Das TK; Rattan A
    Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
    Das S
    Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in pulmonary tuberculosis.
    Ashtekar MD; Samuel AM
    J Clin Lab Immunol; 1985 Oct; 18(2):91-5. PubMed ID: 3935794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
    Tsai JF; Tsai JH; Chang WY
    Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in healthy persons.
    Jans H; Dybkjaer E; Halberg P
    Scand J Rheumatol; 1982; 11(4):194-8. PubMed ID: 7178855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of circulating immune complexes by polyethyleneglycol precipitations complement consumption test in urological malignant diseases].
    Sakai S; Kato N; Ito Y; Matsuda S; Koide T; Deguti T; Kuriyama M; Ban Y; Nishiura T; Tei K
    Hinyokika Kiyo; 1984 Nov; 30(11):1611-7. PubMed ID: 6543290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the platelet alloantigen (PlA1) in circulating immune complexes of normal human sera.
    Wautier JL; Boizard B; Doan R; Caen JP; Hartmann L
    Cancer Immunol Immunother; 1982; 13(1):44-7. PubMed ID: 6760957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
    Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
    Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation)].
    Coppo R; De Marchi M; Basolo B; Martina G; Rollino C; Boero R; Giraudo G; Rossano C; Quarello F; Piccoli G
    Arch Sci Med (Torino); 1982; 139(4):381-92. PubMed ID: 6984818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.